Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972M J van den Bent, O Chinot, W Boogerd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patientsM Klein, M J Taphoorn, J J Heimans, et al.
Neurology|October 22, 1998
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology GroupM J van den Bent, J M Kros, J J Heimans, et al.
Psycho-Oncology|February 26, 2011
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-studyC M T Schilder, C Seynaeve, S C Linn, et al.
Critical Reviews in Oncology/Hematology|December 29, 2009
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factorsC M T Schilder, C Seynaeve, S C Linn, et al.
Neurology|November 26, 2009
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomideH J Dubbink, W Taal, R van Marion, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coinP Alberti, E Rossi, D R Cornblath, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
Pageof 6